Press release
Prostatitis Therapeutics - Key Players Analysis Angelini, Aquinox Pharmaceuticals, Inc., TFPHARMA
Prostatitis is an infection or inflammation of the prostate gland that can lead to various syndromes with varying clinical features. The term prostatitis is defined as microscopic inflammation of the tissue of the prostate gland and it occurs due to a broad range of clinical conditions. The National Institutes of Health (NIH) has recognized and defined a classification system for prostatitis in 1999.
Browse report sample at: https://www.psmarketresearch.com/market-analysis/prostatitis-therapeutics-pipeline/report-sample
*Drug Candidates with Oral Route of Administration tend to Increase Patient Compliance
The drug candidates of prostatitis pipeline are in different stages of development. Among them, majority of drugs are being developed to be administered by oral route. For instance, Prulifloxacin, a Phase II drug candidate by Angelini Acraf SpA, is being developed to be administered by oral route. Oral route increases the patient compliance as it does not require the assistance of other healthcare professionals. It is the prodrug of ulifloxacin a broad-spectrum fluoroquinolone antibacterial agent that blocks the type II DNA topoisomerase.
Some of the key players developing drugs for the treatment of prostatitis therapeutics include Angelini Acraf SpA, TFPHARMA, and Aquinox Pharmaceuticals, Inc.
Browse report at: https://www.psmarketresearch.com/market-analysis/prostatitis-therapeutics-pipeline
Prostatitis Therapeutics Pipeline Analysis
• By Phase
• By Molecule Type
• By Route of Administration
• By Company
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prostatitis Therapeutics - Key Players Analysis Angelini, Aquinox Pharmaceuticals, Inc., TFPHARMA here
News-ID: 1416948 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for Prostatitis
Chronic Bacterial Prostatitis Drugs Market Future Business Scope Analysis Report …
" The global market for chronic bacterial prostatitis drugs is projected to reach approximately $1.2 billion in 2024, driven by increasing awareness of the condition and the demand for effective treatment solutions. The market is anticipated to expand significantly, with a projected value of around $2.3 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of 7.0% over the forecast period from 2025 to 2034."
Exactitude Consultancy., Ltd. released a…
Diuretic and Anti-inflammatory Pill for Prostatitis Treatment: Natural Choice wi …
Diuretic and Anti-inflammatory Pill offers a natural, dual-action approach for prostatitis relief and prevention, making it a popular alternative to traditional treatments with fewer side effects. With over 50 herbs that boost immunity and reduce inflammation, this TCM formula not only alleviates painful symptoms but also helps prevent recurrence, all while supporting overall health.
Globally, billions of people use traditional medicine for health and well-being. Recently, China has deepened its collaboration…
Chronic Bacterial Prostatitis Market Size, Dynamics, Country Share, Trends & Com …
Chronic Bacterial Prostatitis market research report helps businesses draw the strategies about sales, marketing, and promotion. The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market. This market document provides major statistics on the market status of global and regional manufacturers and is a helpful source of assistance and direction for companies and individuals interested in the healthcare industry. In the…
Prostatitis Treatment Market Size to Surge Vigorously during the Forecast Period
The treatment of prostatitis, primarily includes pharmaceuticals and minimally invasive surgical systems. The need for the treatment of prostatitis is rising due to the high rate of infection. Currently, the U.S. is highly affected country for the prostatitis which is lowering the quality of life with painful symptoms that are difficult to manage. In addition, prostatitis is frequently described as an infection of the prostate. Where only 5 to 10%…
Unique treatment for erectile dysfunction and retrograde ejaculation due to BPH …
Treatment with drugs and surgeries of enlarged prostate or benign prostatic hyperplasia (BPH) and chronic prostatitis /chronic pelvic pain syndrome (CP/CPPS) causes sexual dysfunction with the devastating symptom, such as erectile dysfunction, retrograde ejaculation and loss of libido. The only natural therapy with Dr Allen's Device has been working very well for men with BPH and chronic prostatitis during the last decade without side effects.
Men with BPH and CP/CPPS can…
Prostatitis Therapeutics Pipeline Analysis Report - Clinical Trials & Results, P …
The study analyzed that the prostatitis therapeutics pipeline comprises 11 drug candidates in different stages of development. Prostatitis is an infection or inflammation of the prostate gland that can lead to various syndromes with varying clinical features. The term prostatitis is defined as microscopic inflammation of the tissue of the prostate gland and it occurs due to a broad range of clinical conditions. The National Institutes of Health (NIH) has…
